Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Presentation TCT 2025

Case in the Box– Venous– IVUS and Scaffold for DVT

Presenter: Erin Murphy

October 28, 2025

Presentation TCT 2025

Use of PAT and Other Perfusion Techniques in PAD/CLTI

Presenter: Teresa L. Carman

October 28, 2025

Presentation TCT 2025

Insights into PAD Pathogenesis from LIFE-BTK Substudies

Presenter: Sahil A. Parikh

October 28, 2025

Presentation TCT 2025

Inflow / Outflow & Optimization

Presenter: Erin Murphy

October 26, 2025

Presentation TCT 2025

Stent Occlusion - Management

Presenter: Mahmood K. Razavi

October 26, 2025

Presentation TCT 2025

Stent Technology for Deep Veins – Isn’t There Anything New?

Presenter: Jon C. George

October 26, 2025

Presentation TCT 2025

State of the Evidence for Deep Venous Intervention

Presenter: Rahul S. Patel

October 26, 2025

Presentation TCT 2025

Venous Thrombectomy – All the Toys

Presenter: S. Jay Mathews

October 26, 2025

Presentation TCT 2025

The Vein Advantage: Venous Arterialization for CLI

Presenter: Laura Petrikovic

October 25, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

L.A. McKeown

June 17, 2025

Presentation Fellows 2025

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Presenter: S. Jay Mathews

May 18, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

Advertisement

Case in the Box– Venous– IVUS and Scaffold for DVT

Use of PAT and Other Perfusion Techniques in PAD/CLTI

Insights into PAD Pathogenesis from LIFE-BTK Substudies

Inflow / Outflow & Optimization

Stent Occlusion - Management

Stent Technology for Deep Veins – Isn’t There Anything New?

State of the Evidence for Deep Venous Intervention

Venous Thrombectomy – All the Toys

The Vein Advantage: Venous Arterialization for CLI

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

What’s Going to Be Hot at ACC 2025?

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content